| Product name | PRPF39 Polyclonal Antibody |
| Immunogen | Synthesized peptide derived from the Internal region of human PRPF39 at AA range: 240-320 |
| Host | Rabbit |
| Reactivity | Human,Mouse |
| Applications | WB,IHC,IF,ELISA |
| Applications notes | Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000;IHC 1:100-1:300;ELISA 1:40000;IF 1:50-200 |
| Clonality | Polyclonal |
| Preparation method | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Alternative | PRPF39; Pre-mRNA-processing factor 39; PRP39 homolog |
| Formulation | Liquid solution |
| Concentration | 1 mg/ml |
| Molecular weight | 74kD |
| Storage buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Storage instructions | Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing. |
| Shipping | Gel pack with blue ice. |
| Precautions | The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product. |
| Background | PRPF39 also termed as Pre mRNA processing factor 39 or PRP39 homolog is a 669 amino acid protein, which contains 7 HAT repeats and belongs to the PRP39 family. PRPF39 localizes in nucleus and may play a role in mRNA splicing. |
| Gene ID | 55015 |
| Alternative | PRPF39; Pre-mRNA-processing factor 39; PRP39 homolog |
| Others | PRPF39 Polyclonal Antibody detects endogenous levels of PRPF39 protein. |
| Accession | Q86UA1 |
| Observed Band(KD) | 74 |
You must be logged in to post a review.
Reviews
There are no reviews yet.